Company intelligence
F-Prime
About F-Prime
F-Prime enables companies to turn their boldest ambitions into world-changing breakthroughs in life sciences, technology, healthtech + services, and crypto. Our legacy spans over 50 years, built on the belief that the best investors share the same entrepreneurial spirit of the founders they back—and that conviction still guides us today. In healthcare, we focus on therapeutics, medtech, and healthtech + services in a stage-agnostic fashion. In technology, we focus on enterprise software, fintech and frontier tech, and crypto. While we’re early-stage investors by choice, we’ll back exceptional teams at any stage. Today, our $5.3 billion under management support breakthroughs across healthcare and technology. Our seasoned team of scientists, engineers, physicians, operators, and investors bring real world expertise to help companies accelerate their path to scalable growth, always with an eye towards a shared vision—achieving something incredible.
Verified activity
Signals from F-Prime
4 published signals
Presence & Recognition
F-Prime employee David Baker and Ryan Watts were named to the Fierce 50 of 2026 by Fierce Biotech.
Reported by F-Prime
Presence & Recognition
F-Prime hosted a group of healthcare leaders at Lord's for the England vs. Pakistan match.
Reported by F-Prime
Capital & Finance
F-Prime supported Groma on its $17.5M strategic equity round to accelerate the development of its onchain infrastructure, expand to new cities, and scale the marketing and distribution of GromaCoin.
Reported by F-Prime
Research & Knowledge
F-Prime published a research piece breaking down the stablecoin card market and exploring the evolution of the ecosystem from vertically integrated providers toward a more modular, specialized model.
Reported by F-Prime